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Catalase is an autoantigen in Crohn’s disease (CD) and other inflammatory bowel diseases (IBD). 
Vaccines are contaminated with catalase and can be a cause of CD as previously described.1
Glycoprotein 2 (GP2) is another autoantigen linked to CD.2,3
Tyrosinase and GP100 are autoantigens linked to vitiligo.4,5
Vaccines are contaminated with numerous animal proteins.6 The role of animal protein contaminated 
vaccines in the etiology of type 1 diabetes (T1D) and neuromyelitis optica spectrum disorders 
(NMOSD), were previously described.7–9
Methods
Uniprot10 and BLASTP11 are used to determine homology between human proteins and animal proteins 
that contaminate vaccines.
Results

















As previously described for T1D, low affinity self reactive (LASR) T cells that barely qualify to be 
positively selected in the thymus, can have high enough affinity to self peptides to be functional and 
cause autoimmune disease upon activation.7 T cells with T cell receptors (TCR) that recognize peptides 
that differ by as little as one amino acid from a self peptide, can be positively selected and migrate to 
the periphery.12
If homology is 100%, animal derived peptides being identical to self peptides, have a low probability of
causing autoimmune disease. This is because T cells that bind self peptides with high affinity would be 
negatively selected in the thymus. With 42%-90% homology between human and animal proteins 
shown above, there are many regions where protein sequence is identical except for one to two amino 
acid difference. Sample sequence results are shown below highlighting autoepitopes aligning to near-
identical regions. These peptides from near-identical regions can be expected to activate LASR T cells, 
resulting in autoimmune disease. Live viruses or aluminum adjuvants in subunit vaccines provide the 
necessary innate immune system derived costimulation13 required for LASR T cell activation.14 It was 
previously shown in the case of T1D, that autoepitopes are indeed located at near-identical regions of 
the proteins.7
Therefore, as in T1D, these animal proteins can be expected to cause the development of autoimmune 
diseases such as Crohn’s and vitiligo.
Evidence from cancer research on LASR T cell mediated autoimmunity
Cancer research has demonstrated that immunization with homologous xenogeneic proteins (such as 
vaccines contaminated with animal proteins that resemble human proteins) results in autoimmunity.15
As Naftzger et al.15 describe, tolerance can be broken by introducing altered antigens. Animal proteins 
are an ideal source of altered antigens. As shown before7 and in sections below, animal proteins contain
numerous regions that are altered compared to human proteins. Yu et al.16 describe another mechanism 
of altered antigens breaking self-tolerance, that involves MHC binding stability. Exposure to peptide 
sequence IMDQVPFSV caused autoimmunity to ITDQVPFSV.
Engelhorn et al.17 describe generation of immune responses to self as a result of presenting numerous 
antigen variants. This is exactly the case with vaccines contaminated with animal cell cultures 
containing thousands of animal proteins that are variants of human proteins.
Skipper et al.18 describe a strong T cell response to YMDGTMSQV on melanoma cells which is a 
single amino acid change from the normal tyrosinase sequence YMNGTMSQV.
The natural purpose of LASR T cells is likely to be cancer defense. With animal protein contaminated 
vaccines, we trigger the cancer response. A cancer related mutation can cause a single amino acid 
alteration in a self peptide. Numerous animal peptides naturally have single amino acid alterations 
compared to human peptides. With thousands of animal proteins contaminating vaccines, a widespread 
cancer response results following vaccination. Thus increasing the probability of autoimmunity as 
described by Engelhorn et al.17
Skin homing receptors - the smoking gun
As described in the case of T1D7, autoreactive CD8+ T cells in vitiligo, also express CCR4 skin 
homing chemokine receptors.19 CD4+ T cells in Crohn’s disease also express CCR4 skin homing 
receptors.20 
The role of yeast (Saccharomyces cerevisiae) contaminated vaccines in the etiology of Systemic Lupus 
Erythematosus (SLE) was previously described.21 Wang et al.22 provide epidemiological evidence of 
vaccines causing SLE and rheumatoid arthritis. Yang et al.23 describe increased expression of CCR4 
skin homing receptors on CD4+ T cells in ankylosing spondylitis, rheumatoid arthritis and SLE as well.
Dendritic cells that capture antigens, imprint T cells with homing receptors corresponding to the 
location where the antigens were captured.24,25 This is evidence that the antigens involved in the above 
diseases were all captured in skin tissue, as would be expected with intramuscular or subcutaneous 
administration of animal protein contaminated vaccines.
Animals don’t like our proteins being injected into them either …
Immunizing mice with human proteins caused the development of vitiligo in mice.15 So, immunizing 
humans with animal proteins resulting in vitiligo (or any number of other autoimmune diseases) comes 
as no surprise at all.
Conclusion
The above findings add to the growing evidence of vaccines inducing autoimmune diseases.22,26–29
Autoantibody and autoreactive T cell levels can vary from person to person. Not everyone will develop 
overt disease. For every case of diagnosed autoimmune disease, there are numerous subclinical cases. 
Balaji et al.30 describe long term persistent inflammation following typhoid vaccine and decreased 
adiponectin levels in asymptomatic children. A likely case of autoimmunity against adiponectin as 
previously described.31 These subclinical diseases could shave decades off your life. So “rare” 
diagnosed vaccine adverse events are the tip of the iceberg.
It is quite obvious that there are fundamental problems with vaccine design and safety. Vaccine 
designers need to go back to the drawing board. We need vaccines that are safe by design.29,32 
Detailed sample BLASTP results
Human GP2 vs. bovine GP2
pancreatic secretory granule membrane major glycoprotein GP2 precursor [Bos taurus]
 NP_001069418.2 534 1
See 1 more title(s)
GenPept  Graphics  Next MatchPrevious Match
Alignment statistics for match #1
Score Expect Identities Positives Gaps
1214 bits(2856) 0.0 415/540(77%) 431/540(79%) 9/540(1%)
Query  1    MPHLMERMVGSGLLWLALVSCILTQASAVQRGYGNPIEASSYGLDLDCGAPGTPEAHVCF  60
            M +L+ERM     LWLAL S ILT  S  Q GY N     SY  DLDCGAPGTPEA+ CF
Sbjct  1    MSQLLERM--TSVLWLALASYILTLSSTEQQGYRNSTNTGSYEKDLDCGAPGTPEAQLCF  58
Query  61   DPCQNYTLLDEPFRSTENSAGSQGCDKNMSGWYRFVGEGGVRMSETCVQVHRCQTDAPMW  120
            DPCQNYTLL+EPFRSTEN    QGCD +  GWYRFVG+GGVRM E CV   RCQT AP+W
Sbjct  59   DPCQNYTLLNEPFRSTENTEDIQGCDSDKHGWYRFVGDGGVRMPEDCVPTFRCQTSAPLW  118
Query  121  LNGTHPALGDGITNHTACAHWSGNCCFWKTEVLVKACPGGYHVYRLEGTPWCNLRYCTVP  180
             LNGTHP LG+GI N TACAHWSGNCC WKTEVLVKACPG Y VYRLEGTP C LRYCT  
Sbjct  119  LNGTHPGLGEGIVNRTACAHWSGNCCLWKTEVLVKACPGPYYVYRLEGTPQCSLRYCT--  176
Query  181  RDPSTVEDKCEKACRPEEEC-LALNSTWGCFCRQDLNSSDVHSLQPQLDCGPREIKVKVD  239
              DP T EDKC+  CRPEEEC L    TWGCFCRQDLN SDVHSLQPQLDCG  EIKV  D
Sbjct  177  -DPATAEDKCDRTCRPEEECRLV-SGTWGCFCRQDLNVSDVHSLQPQLDCGDTEIKVSLD  234
Query  240  KCLLGGLGLGEEVIAYLRDPN--CSSILQTEERNWVSVTSPVQASACRNILERNQTHAIY  297
             KCLLG LG G+EV AYLRD N  CSS  Q EE NW+SVT P QA AC NILERNQTHAIY
Sbjct  235  KCLLGSLGFGDEVHAYLRDGNWNCSSLRQSEEENWISVTNPTQAGACGNILERNQTHAIY  294
Query  298  KNTLSLVNDFIIRDTILNINFQCAYPLDMKVSLQAALQPIVSSLNVSVDGNGEFIVRMAL  357
               NTLSLVNDFIIRDTIL INFQCAYPLDMKVSLQ ALQPIVSSLN+ VDG GEF VRMAL
Sbjct  295  INTLSLVNDFIIRDTILSINFQCAYPLDMKVSLQMALQPIVSSLNITVDGEGEFTVRMAL  354
Query  358  FQDQNYTNPYEGDAVELSVESVLYVGAILEQGDTSRFNLVLRNCYATPTEDKADLVKYFI  417
             FQDQ+YT PYEG AV LSVES LYVG ILE GDTSRFNLVL NCYATPTEDK D VKYFI
Sbjct  355  FQDQDYTSPYEGTAVMLSVESMLYVGTILERGDTSRFNLVLKNCYATPTEDKTDPVKYFI  414
Query  418  IRNSCSNQRDSTIHVEENGQSSESRFSVQMFMFAGHYDLVFLHCEIHLCDSLNEQCQPSC  477
              IRNSC NQRDSTI VEENG S ESRFSVQMF FAG YDLVFLHCE+ LCD   E+CQPSC
Sbjct  415  IRNSCPNQRDSTISVEENGVSAESRFSVQMFKFAGNYDLVFLHCEVSLCDFIKEECQPSC  474
Query  478  SRSQVRSEVPAIDLARVLDLGPITRRGAQSPGVMNGTPSTAGFLVAWPMVLLTVLLAWLF  537
              SRSQ RSE  AID ARVLDLGPITR GAQS GVM GTP TAGFLVAWP+VLL VLLA LF
Sbjct  475  SRSQLRSEGVAIDPARVLDLGPITRKGAQSLGVMSGTPNTAGFLVAWPLVLLPVLLAGLF  534
Human tyrosinase vs. bovine tyrosinase
Autoepitopes identified by Kemp et al.4 are highlighted below showing that 3 out of 4 epitopes align to 
near-identical regions, exactly as would be expected for LASR T cell mediated autoimmunity.
TPA: tyrosinase precursor [Bos taurus]
 DAA14054.1 530 1
See 2 more title(s)
GenPept  Graphics  Next MatchPrevious Match
Alignment statistics for match #1
Score Expect Method Identities Positives Gaps
983 bits(2541) 0.0 Compositional matrix adjust. 461/530(87%) 493/530(93%) 1/530(0%)
Query  1    MLLAVLYCLLWSFQTSAGHFPRACVSSKNLMEKECCPPWSGDRSPCGQLSGRGSCQNILL  60
            MLLA LYCLLWSF+TSAGHFPRAC SSK+L EKECCPPW+GD SPCG+LSGRGSCQ+++L
Sbjct  1    MLLAALYCLLWSFRTSAGHFPRACASSKSLTEKECCPPWAGDGSPCGRLSGRGSCQDVIL  60
Query  61   SNAPLGPQFPFTGVDDRESWPSVFYNRTCQCSGNFMGFNCGNCKFGFWGPNCTERRLLVR  120
            S APLGPQFPFTGVDDRESWPS+FYNRTCQC  NFMGFNCG+CKFGF GP CTERRLLVR
Sbjct  61   STAPLGPQFPFTGVDDRESWPSIFYNRTCQCFSNFMGFNCGSCKFGFRGPRCTERRLLVR  120
Query  121  RNIFDLSAPEKDKFFAYLTLAKHTISSDYVIPIGTYGQMKNGSTPMFNDINIYDLFVWMH  180
            RNIFDLS PEK+KF AYLTLAKHT S DYVIP GTYGQM +G+TP+FND+++YDLFVWMH
Sbjct  121  RNIFDLSVPEKNKFLAYLTLAKHTTSPDYVIPTGTYGQMNHGTTPLFNDVSVYDLFVWMH  180
Query  181  YYVSMDALLGGSEIWRDIDFAHEAPAFLPWHRLFLLRWEQEIQKLTGDENFTIPYWDWRD  240
             YYVS D LLG      SE+WRDIDFAHEAP    FLPWHRLFLL  WEQEIQKLTGDENFTIPYWDWRD
Sbjct  181   YYVSRDTLLGDSEVWRDIDFAHEAPGFLPWHRLFLLLWEQEIQKLTGDENFTIPYWDWRD  240
Query  241  AEKCDICTDEYMGGQHPTNPNLLSPASFFSSWQIVCSRLEEYNSHQSLCNGTPEGPLRRN  300
             AE CD+CTDEYMGG++P     NPNLLSPASFFSSWQIVCSRLEEYNS    Q+LCNGT  EGPL   RN
Sbjct  241  AENCDVCTDEYMGGRNPANPNLLSPASFFSSWQIVCSRLEEYNSRQALCNGTSEGPLLRN  300
Query  301  PGNHDKSRTPRLPSSADVEFCLSLTQYESGSMDKAANFSFRNTLEGFASPLTGIADASQS  360
            PGNHDK+RTPRLPSSADVEFCLSLTQYESGSMDKAANFSFRNTLEGFA P+TGIADASQS
Sbjct  301  PGNHDKARTPRLPSSADVEFCLSLTQYESGSMDKAANFSFRNTLEGFADPVTGIADASQS  360
Query  361  SMHNALHIYMNGTMSQVQGSANDPIFLLHHAFVDSIFEQWLRRHRPLQEVYPEANAPIGH  420
            SMHNALHIYMNGTMSQV GSANDPIFLLHHAFVDSIFEQWLR++ PLQ+VYPEANAPIGH
Sbjct  361  SMHNALHIYMNGTMSQVPGSANDPIFLLHHAFVDSIFEQWLRKYHPLQDVYPEANAPIGH  420
Query  421  NRESYMVPFIPLYRNGDFFISSKDLGYDYSYLQDSDPDSFQDYIKSYLEQASRIWSWLLG  480
             NRESYMVPFIPLYRNGDFFISSKDLGYDYSYLQDS+PD    FQDYIK  YLEQA  RIW   WL+G
Sbjct  421   NRESYMVPFIPLYRNGDFFISSKDLGYDYSYLQDSEPDI  FQDYIKPYLEQAQRIWPWLIG  480
Query  481  AAMVGAVLTALLAGLVSLLCRHKRKQLPEEKQPLLMEKEDYHSL-YQSHL  529
            AA+VG+VLTA+L GL SLLCR KR QLPEEKQPLLMEKEDYH+L YQSHL
Sbjct  481  AAVVGSVLTAVLGGLTSLLCRRKRNQLPEEKQPLLMEKEDYHNLMYQSHL  530
Human gp100 vs. pig gp100
melanocyte protein PMEL [Sus scrofa]
 XP_020947439.1 663 1
GenPept  Graphics  Next MatchPrevious Match
Alignment statistics for match #1
Score Expect Identities Positives Gaps
1561 bits(3673) 0.0 537/667(81%) 544/667(81%) 36/667(5%)
Query  1    MDLVLKRCLLHLAVIGALLAVGATKVPRNQDWLGVSRQLRTKAWNRQLYPEWTE--AQRL  58
            MDLVL  CLLH AV GA LAVGAT  PR  DWLGVSRQLRTKAWN QLYPEWTE  A   
Sbjct  27   MDLVLRKCLLHVAVMGAFLAVGATEGPRGRDWLGVSRQLRTKAWNSQLYPEWTEIRAP--  84
Query  59   DCWRGGQVSLKVSNDGPTLIGANASFSIALNFPGSQKVLPDGQVIWVNNTIINGSQVWGG  118
            DCWRGG VSLKVSNDGPTLIGANASFSIAL FP SQKVLPDGQVIW NNTIINGSQVWGG
Sbjct  85   DCWRGGRVSLKVSNDGPTLIGANASFSIALHFPKSQKVLPDGQVIWANNTIINGSQVWGG  144
Query  119  QPVYPQETDDACIFPDGGPCPSGSWSQKRSFVYVWKTWGQYWQVLGGPVSGLSIGTGRAM  178
             QPVYPQE +  CIFPDG  CP G  SQ RSFVYVWK WGQYWQVLGGPVSGLSIGTG A 
Sbjct  145  QPVYPQEPNATCIFPDGAACPPGPSSQRRSFVYVWKAWGQYWQVLGGPVSGLSIGTGKAV  204
Query  179  LGTHTMEVTVYHRRGSRSYVPLAHSSSAFTITDQVPFSVSVSQLRALDGGNKHFLRNQPL  238
             LGTHTMEVTVYHRRGS SYVPLAHS SAFT+TDQVPFSVSVSQL ALD GNK FLR QPL
Sbjct  205  LGTHTMEVTVYHRRGSQSYVPLAHSRSAFTVTDQVPFSVSVSQLQALDRGNKRFLRKQPL  264
Query  239  TFALQLHDPSGYLAEADLSYTWDFGDSSGTLISRALVVTHTYLEPGPVTAQVVLQAAIPL  298
             TFALQLHDPSGYLA ADLSYTWDFGD  GTLISRALVVTHTYLE GPVTAQVVLQAAIPL
Sbjct  265  TFALQLHDPSGYLAGADLSYTWDFGDNTGTLISRALVVTHTYLESGPVTAQVVLQAAIPL  324
Query  299  TSCGSSPVPGTTDGHRPTAEAPNTTAGQVPTTEVVGTTPGQAPTAEPSGTTSVQVPTTEV  358
             TSCGSSPVPGTTDG  PTAE P TTA QVPTTEVVGTTPGQ PTAEPSGTT VQVPT E 
Sbjct  325  TSCGSSPVPGTTDGPVPTAETPGTTAKQVPTTEVVGTTPGQMPTAEPSGTTAVQVPTAE-  383
Query  359  ISTAPVQMPTAESTGM--TPEKVPVSEVMGTTLAEMSTPEATGMTPAEVSIVVLSGTTAA  416
                          GM  TP+  P SEV GTT A M T E     P        SGTT A
Sbjct  384  --------------GMGTTPDQAPTSEVRGTTPAVMPTVE-----P--------SGTTVA  416
Query  417  QVTTTEWVETTARELPIPEPEGPDASSIMSTESITGSLGPLLDGTATLRLVKRQVPLDCV  476
             QVTTTE VETTA E P PEPE PD S  M TE  TGS  PLLDGTATL LVKRQVPLDCV
Sbjct  417  QVTTTELVETTAGEVPTPEPESPDVSPFMPTEGLTGSQSPLLDGTATLILVKRQVPLDCV  476
Query  477  LYRYGSFSVTLDIVQGIESAEILQAVPSGEGDAFELTVSCQGGLPKEACMEISSPGCQPP  536
             LYRYGSFS TLDIVQGIESAEILQAVPS EGDAFELTVSCQGGLPKEACM+ISSPGCQPP
Sbjct  477  LYRYGSFSLTLDIVQGIESAEILQAVPSSEGDAFELTVSCQGGLPKEACMDISSPGCQPP  536
Query  537  AQRLCQPVLPSPACQLVLHQILKGGSGTYCLNVSLADTNSLAVVSTQLIMPGQEAGLGQV  596
            AQRLCQPV PSPACQLVLHQ+LKGGSGTYCLNVSLADTNSLA VSTQL+MPGQE GLGQ 
Sbjct  537  AQRLCQPVSPSPACQLVLHQVLKGGSGTYCLNVSLADTNSLAMVSTQLVMPGQESGLGQA  596
Query  597  PLIVGILLVLMAVVLASLIYRRRLMKQD--FSVPQLPHSSSHWLRLPRIFCSCPIGENSP  654
             PL VGILLVL A  LASLIYRRRLMKQD     PQLPH  S WLRLP  F SCP+GENSP
Sbjct  597  PLFVGILLVLIALLLASLIYRRRLMKQDSALPLPQLPHGRSPWLRLPWGFRSCPVGENSP  656
Query  655  LLSGQQV  661
             LLSGQQV
Sbjct  657  LLSGQQV  663
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